FDA Committee Gives New Cancer Surgery Tech a Positive Vote
Although most of the FDA's Medical Imaging Drugs Advisory Committee supported LUMISIGHT (pegulicianine), which aims to detect residual cancer during lumpectomy, some cite safety concerns.
Source: medscape.com